Medical Oncologist
Your treatment regimen explained
Abiraterone With ADT, Docetaxel and Radiation: — What Each Part of the Regimen Does
Your oncologist has prescribed four treatments at once because each one does something the others cannot. This page explains what abiraterone, ADT, docetaxel and radiation each contribute, and what to expect as you move through the regimen.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Four treatments, four jobs — ADT, abiraterone, docetaxel and radiation each target prostate cancer through a different mechanism.
- Abiraterone reaches where ADT cannot — ADT blocks testosterone from the testes. Abiraterone blocks androgens made in the adrenal glands and inside the tumour itself.
- Docetaxel targets dividing cells — Chemotherapy attacks cancer cells that are actively growing — something hormone treatment alone cannot stop.
- Radiation treats the source — Radiation is directed at the prostate gland to treat the primary tumour directly.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
This regimen combines four treatments because prostate cancer needs to be attacked in more than one way. ADT and abiraterone cut off the hormones that fuel tumour growth. Docetaxel kills rapidly dividing cancer cells. Radiation treats the tumour in the prostate directly. Each part does a job the others cannot.
Why are you being given four treatments at once?
Prostate cancer cells are driven mainly by androgens — male hormones such as testosterone. Cutting off that fuel slows or stops their growth, but it is rarely enough on its own for high-risk or advanced disease.
ADT reduces testosterone produced by the testes. Abiraterone reduces androgens produced by the adrenal glands and by the tumour itself — places ADT cannot reach. Docetaxel kills cancer cells that are still dividing despite hormone suppression. Radiation targets the tumour in the prostate directly.
Together, these four treatments are used when a single approach would leave one of those pathways open.
What do you need to do while on this regimen?
- Take abiraterone on an empty stomachFood — even a small amount — sharply changes how much abiraterone your body absorbs. Your prescribing team will tell you exactly when to take it relative to meals.
- Take prednisone every day without missing dosesPrednisone is prescribed alongside abiraterone to prevent a specific hormonal side effect. It is not an optional part of the regimen.
- Keep every ADT injection appointmentMissing an injection allows testosterone to rise and can reduce how well the whole regimen works.
- Tell your team about any other medicine or supplementAbiraterone interacts with a number of common medicines and can be affected by herbal or Ayurvedic preparations. Tell your team before starting anything new.
- Report new symptoms before your next scheduled visitChest pain, one-sided leg swelling, shortness of breath, fever or new bone pain all need same-day contact, not a wait until your next appointment.
What does each term in your treatment plan mean?
- ADT (Androgen Deprivation Therapy)
- Injections given at regular intervals — the frequency depends on which formulation is prescribed — that stop the testes from producing testosterone. This is usually the first hormone treatment started and continues throughout the regimen.
- Abiraterone (brand name: Zytiga)
- A tablet taken daily that blocks a specific enzyme called CYP17. This stops the adrenal glands and the tumour itself from making androgens — cutting off a source of hormone fuel that ADT alone cannot reach.
- Prednisone
- A low-dose steroid taken every day alongside abiraterone. It is not chemotherapy. It is prescribed specifically to prevent a rise in blood pressure and fluid retention that occurs when CYP17 is blocked.
- Docetaxel
- A chemotherapy agent given through a drip in a day-care or outpatient setting, for a set number of cycles agreed before treatment starts. It works by interfering with cancer cells that are actively dividing.
- Radiation therapy
- A course of precisely targeted energy beams aimed at the prostate gland. It is used to treat the primary tumour and is planned and delivered by a radiation oncologist as either a standard multi-week course or a shorter hypofractionated schedule.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
How does the timing of the four treatments fit together?
ADT is usually started first, often several weeks before the other treatments begin. Abiraterone and prednisone are daily tablets that run throughout the treatment course rather than in cycles.
Docetaxel is given as an infusion at set intervals, for a fixed number of cycles. Your oncologist will specify both before treatment starts.
Radiation is generally planned around the docetaxel schedule — your radiation oncologist will explain the exact sequence. You will often be seen by two specialist teams whose plans are coordinated with each other.
What do families ask most about this combination?
Does needing four treatments mean my cancer is very advanced?
Not necessarily. This combination is used for high-risk localised prostate cancer as well as for cancer that has spread to nearby lymph nodes or more distant sites. The number of treatments reflects the biology of prostate cancer — which responds to hormones — rather than a simple measure of how far the disease has progressed. Your oncologist chose this regimen because the evidence supports it for your specific stage and risk group.
What does abiraterone add if I am already on ADT?
ADT works by stopping the testes from making testosterone, which accounts for most of the body's androgen production. However, the adrenal glands and sometimes the tumour itself continue to produce androgens at lower levels — enough to drive tumour growth in some patients. Abiraterone blocks the enzyme responsible for androgen production at those additional sites. Adding it to ADT produces a deeper level of hormone suppression than either treatment achieves alone.
Will I lose my hair during docetaxel?
Hair loss is a common effect of docetaxel. It typically affects the scalp and sometimes the eyebrows, eyelashes and body hair. Hair usually begins to fall out within the first few cycles and generally regrows after chemotherapy ends, though the texture or colour may be temporarily different. Your team can advise on scalp cooling if it is available at your centre and refer you to support resources.
Is the prednisone making me immunocompromised?
The dose of prednisone used alongside abiraterone is low and is given for a specific pharmacological reason — not as an immune suppressant. It is very different from the higher doses used to treat inflammatory conditions. At this dose, significant immune suppression is not expected, though any new infection, fever or unusual symptoms should still be reported promptly to your team rather than managed at home.
How long will I be on this regimen overall?
Docetaxel runs for a fixed number of cycles that your oncologist specifies at the start. Radiation is a finite course with a defined end date. ADT and abiraterone are typically continued for longer — the duration depends on your response, your staging, and your oncologist's assessment at each review. There is no fixed answer that applies to every patient, and the plan is revisited regularly.
What happens if one part of the regimen has to stop?
The four components can be adjusted independently. If docetaxel needs to be paused or its dose reduced because of side effects, this does not automatically stop abiraterone or radiation. Decisions about each part are made separately, based on what is causing the problem and how well each treatment is being tolerated. Your team will explain which adjustments are being made and what the plan is from that point.
Did you know?
The addition of abiraterone to ADT and docetaxel was evaluated in the international PEACE-1 trial, which enrolled men with metastatic hormone-sensitive prostate cancer.
ESMO incorporated findings from PEACE-1 into its clinical practice guidance, describing the triplet combination as improving outcomes in patients with high-volume disease.
Source: PEACE-1 trial; ESMO Clinical Practice Guidelines for Prostate Cancer
Explore 50 more Prostate Cancer Targeted Medicines topics
Drug Deep Dive: Abiraterone (Zytiga)
- Abiraterone (Zytiga, Abirapro, Abretone): The Complete Patient Guide
- Abiraterone Interactions: Steroids, BP Medicines and Herbal Products
- Abiraterone Myths: Steroids, Weight Gain and 'It Stops Working Fast'
- Abiraterone Price in India: Brand, Generic and Monthly Cost
- Abiraterone Side Effects: The Complete List and Timeline
- Abiraterone Success Rate and Survival: An Honest Look at the Numbers
- Abiraterone With ADT, Docetaxel and Radiation: Your Full Regimen Explained
- Abiraterone in Elderly Patients and Those With Other Illnesses
- Abiraterone in Hormone-Sensitive vs Castration-Resistant Prostate Cancer
- Abiraterone vs Enzalutamide: How to Choose in Prostate Cancer
- Diet and Nutrition While on Abiraterone
- Fatigue, Hot Flushes and Joint Pain on Abiraterone
- Fertility, Pregnancy and Contraception on Abiraterone
- How Does Abiraterone Work? The CYP17 Inhibitor Explained
- How Long Does Abiraterone Take to Work?
- How Long Will You Stay on Abiraterone?
- Liver Enzyme Rises on Abiraterone: Why the First Three Months Matter Most
- Swelling, Low Potassium and High Blood Pressure on Abiraterone
- Tests and Monitoring While You Are on Abiraterone
- When Abiraterone Stops Working: Resistance and What Comes Next
- Who Is Eligible for Abiraterone? Advanced and Metastatic Prostate Cancer
- Why Abiraterone Is Always Given With Prednisolone
- Why Abiraterone Must Be Taken on an Empty Stomach
- Will Insurance or a Government Scheme Pay for Abiraterone?
- Work, Travel and Daily Life on Abiraterone
Drug Deep Dive: Enzalutamide (Xtandi)
- Diet and Nutrition While on Enzalutamide
- Dizziness, Falls and Seizure Risk on Enzalutamide
- Does Enzalutamide Need a Steroid? Why It Differs From Abiraterone
- Enzalutamide (Xtandi, Bdenza, Enzamide): The Complete Patient Guide
- Enzalutamide Interactions: Blood Thinners, Statins and Seizure-Threshold Drugs
- Enzalutamide Myths: 'It's Chemotherapy', Fatigue and Loss of Masculinity
- Enzalutamide Price in India: Brand, Generic and Monthly Cost
- Enzalutamide Side Effects: The Complete List and Timeline
- Enzalutamide Success Rate and Survival: An Honest Look at the Numbers
- Enzalutamide With ADT and Other Prostate Cancer Treatments
- Enzalutamide in Elderly Patients and Those With Other Illnesses
- Enzalutamide in Non-Metastatic vs Metastatic Prostate Cancer
- Enzalutamide vs Abiraterone vs Apalutamide: Choosing an AR Inhibitor
- Fertility, Pregnancy and Contraception on Enzalutamide
- How Does Enzalutamide Work? The Androgen Receptor Signalling Inhibitor Explained
- How Long Does Enzalutamide Take to Work?
- How Long Will You Stay on Enzalutamide?
- Memory, Concentration and Blood Pressure Changes on Enzalutamide
- Severe Fatigue on Enzalutamide: The Commonest Reason Men Stop
- Taking Enzalutamide: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Enzalutamide
- When Enzalutamide Stops Working: Resistance and What Comes Next
- Who Is Eligible for Enzalutamide? Advanced and Metastatic Prostate Cancer
- Will Insurance or a Government Scheme Pay for Enzalutamide?
- Work, Travel and Daily Life on Enzalutamide
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
What is the difference between ADT and abiraterone?
ADT works at the level of the testes, stopping them from producing testosterone through injections given at regular intervals. Abiraterone works at a different site — it blocks an enzyme called CYP17 that is responsible for androgen production in the adrenal glands and in the tumour tissue itself. Because they act at different points in the same pathway, using both together produces a deeper level of hormone suppression than either alone. Prednisone is always added to abiraterone to manage a specific side effect of blocking that enzyme.
Why do I have to take prednisone with abiraterone?
Blocking the CYP17 enzyme causes a build-up of hormones upstream of the block, which can raise blood pressure and cause fluid retention. A low daily dose of prednisone corrects this hormonal imbalance. It is not given for its anti-inflammatory effect and it is not chemotherapy — it is a pharmacological correction built into the abiraterone regimen. Stopping it without speaking to your oncologist first can allow these side effects to appear.
Will docetaxel make me very unwell?
Docetaxel carries real side effects, and some people find the cycles difficult. Common effects include fatigue, hair loss, changes to taste, and numbness or tingling in the hands and feet. Fever after a chemotherapy infusion always needs same-day hospital assessment — your team will give you a number to call and explain exactly what to do if this happens. Many people complete their planned cycles and recover well, but the experience varies and your team will monitor you closely throughout.
When does radiation happen relative to the chemotherapy?
The exact sequence depends on your oncologist's and radiation oncologist's joint plan and may vary between centres. In many protocols, radiation is scheduled after the docetaxel cycles are complete, while ADT and abiraterone continue throughout. In some cases there is overlap. Your radiation oncologist will give you a detailed schedule at the planning appointment, and both teams coordinate so you know exactly what is happening and when.
How long will I stay on abiraterone?
Abiraterone is typically continued beyond the chemotherapy and radiation phases, for a duration your oncologist specifies based on your staging and response. It is not a short-course treatment — it is a daily tablet you continue taking for as long as it is working and you are tolerating it. The duration is reviewed at each appointment. If the cancer stops responding, or if side effects become unmanageable, your oncologist will discuss what the next step is.
After docetaxel ends, do I stop all treatment?
No. Docetaxel is a fixed-cycle part of the regimen, but ADT and abiraterone continue after it ends. Radiation also has its own end point. The hormone treatments are generally the longest-running part of the regimen, and your oncologist will define the planned duration at each review. Finishing chemotherapy is a significant milestone, but it does not mean treatment is over — the hormone suppression that forms the backbone of the regimen continues.